Surgery Revenue Per Share from 2010 to 2024

SGRY Stock  USD 23.39  0.38  1.65%   
Surgery Partners Revenue Per Share yearly trend continues to be fairly stable with very little volatility. Revenue Per Share will likely drop to 19.39 in 2024. Revenue Per Share is the amount of revenue generated by Surgery Partners per share of stock, calculated by dividing total revenue by the average number of shares outstanding. View All Fundamentals
 
Revenue Per Share  
First Reported
2010-12-31
Previous Quarter
21.83930007
Current Value
19.39
Quarterly Volatility
12.45339054
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Surgery Partners financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgery Partners' main balance sheet or income statement drivers, such as Depreciation And Amortization of 80.6 M, Interest Expense of 148.4 M or Selling General Administrative of 80.8 M, as well as many indicators such as Price To Sales Ratio of 1.52, Dividend Yield of 0.0014 or PTB Ratio of 2.12. Surgery financial statements analysis is a perfect complement when working with Surgery Partners Valuation or Volatility modules.
  
Check out the analysis of Surgery Partners Correlation against competitors.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

Latest Surgery Partners' Revenue Per Share Growth Pattern

Below is the plot of the Revenue Per Share of Surgery Partners over the last few years. It is the amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding. Surgery Partners' Revenue Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Surgery Partners' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 23.6910 Years Trend
Slightly volatile
   Revenue Per Share   
       Timeline  

Surgery Revenue Per Share Regression Statistics

Arithmetic Mean21.40
Geometric Mean16.90
Coefficient Of Variation58.19
Mean Deviation10.47
Median23.85
Standard Deviation12.45
Sample Variance155.09
Range32.7321
R-Value0.68
Mean Square Error89.33
R-Squared0.47
Significance0.01
Slope1.90
Total Sum of Squares2,171

Surgery Revenue Per Share History

2024 19.39
2023 21.84
2022 27.62
2021 30.72
2020 38.14
2019 37.93
2018 36.88

About Surgery Partners Financial Statements

Surgery Partners investors use historical fundamental indicators, such as Surgery Partners' Revenue Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Surgery Partners. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Revenue Per Share 21.84  19.39 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.